Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is a once-weekly injection, and the short answer is: you can inject it on any day of the week, at any time of day, with or without food. What matters is keeping to that same day each week, as consistently as possible. That weekly rhythm is what the clinical evidence is built on, and drifting from it can affect how well the medicine settles. As a prescription-only medicine, your prescriber will confirm the timing that works for your individual routine at consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy's dosing schedule was studied across large randomised trials, including the STEP 1 trial published in the New England Journal of Medicine, which followed adults over 68 weeks using a fixed weekly injection regimen. Participants self-administered once a week and achieved an average body-weight reduction of around 15% at the 2.4 mg maintenance dose. The fixed weekly interval is not an arbitrary instruction, semaglutide has a half-life of approximately one week, which is exactly why once-weekly dosing works. Inject more often and the drug accumulates; stretch the gap significantly and the steady-state concentration dips.
What the trials did not mandate was a specific time of day or a specific day of the week. Participants chose what fitted their lives. That flexibility is now reflected in the licensed prescribing information: the NHS semaglutide medicines page confirms that Wegovy can be taken at any time of day, with or without food, on a chosen day that you then keep consistent.
Practically, consistency beats perfection. Picking a day you will genuinely remember (perhaps one with a standing routine already attached to it) matters more than which day you pick.
Most people find it helpful to anchor their injection to something that already happens weekly: a Sunday morning before the week starts, a Wednesday evening after a particular commitment, or a Friday that marks a natural pause. The key is that the anchor is reliable. Semaglutide's long half-life gives you a little room (the prescribing guidance is clear that injections can be given up to two days early or two days late without losing your usual schedule) but that flexibility is a safety net, not a regular habit to lean on.
If you realise you have missed your usual day, check how many days have passed. Fewer than five days since the missed dose: take it as soon as you remember, then return to your original day the following week. Five or more days have passed: skip it and wait for your normal next day. Never inject two doses to make up for a missed one. Your patient information leaflet covers this precisely, and if you are at all uncertain, it is always worth checking with your prescriber or pharmacist rather than guessing.
One thing our prescribers hear regularly: people worry that a single day's variation will undo everything. It will not. The medicine's pharmacokinetics allow for this. The concern worth taking seriously is repeated, large gaps, not the occasional shifted day.
Timing questions and technique questions often arrive together, which makes sense. The when is about your weekly calendar; the how and where are separate considerations that are just as important for a comfortable injection. Wegovy is injected into the fatty tissue just beneath the skin (typically the abdomen, upper thigh or upper arm) and rotating sites each week reduces the risk of local skin reactions. If you are thinking about technique alongside timing, our guide on where to inject semaglutide covers site selection and rotation in detail, and if you are unsure about the physical process of administering the injection itself, our page on whether to pinch your skin when injecting Wegovy walks through that part of the technique clearly.
Storage is part of the practical picture too. Wegovy pens are kept in the fridge at 2–8°C, but they can be left at room temperature for a short window before use. The exact duration is specified in our Wegovy storage guide, always refer to your patient information leaflet for the current confirmed figure rather than relying on general articles. Injecting a pen that has been outside the fridge for longer than the approved window is not recommended.
For a broader look at semaglutide's injection timing across different contexts, the semaglutide injection timing page addresses some of the scheduling questions that apply across both the injection and dose-change stages of treatment.
This is where it helps to be honest: starting a new weekly injection routine does feel slightly odd at first. Looking up best practices before your first dose, checking and re-checking the instructions, that is completely normal. Most people settle into it quickly, because once the day is chosen and the fridge habit is established, the weekly routine becomes just that: routine.
If your circumstances change (shift work that moves your free mornings, travel across time zones, a week where the usual anchor disappears) the two-day window on either side of your normal day handles most of it. For surgical procedures or anything that might affect your dosing schedule, tell your clinical team in advance; NHS England's guidance on weight-management injections specifically flags that your healthcare team, including any anaesthetist, should know you are taking this medicine.
Wegovy is one of two injectable weight-loss medicines licensed in the UK; if you are still weighing up options, our Wegovy overview sets out the full picture, and there is a plain comparison of costs on the Wegovy cost page. When you are ready to check whether you are clinically suitable, checking your eligibility with our prescribers is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.